Novel Biological and Molecular Characterization in Radiopharmaceutical Preclinical Design
In this study, the potential of a digital autoradiography system equipped with a super resolution screen has been evaluated to investigate the biodistribution of a 18F-PSMA inhibitor in a prostate cancer mouse model. Twelve double xenograft NOD/SCID mice (LNCAP and PC3 tumours) were divided into thr...
Guardado en:
Autores principales: | Nicoletta Urbano, Manuel Scimeca, Anna Tolomeo, Vincenzo Dimiccoli, Elena Bonanno, Orazio Schillaci |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ea74e1fb08b448ca4a70a8a0ddcf136 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cancer biotherapy & radiopharmaceuticals
Publicado: (1996) -
Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals
por: Xu Zhou, et al.
Publicado: (2021) - Journal of labelled compounds & radiopharmaceuticals
-
Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals
por: Elisabeth von Guggenberg, et al.
Publicado: (2021) -
Design and synthesis of a new conjugate of a tris(3-hydroxy-4-pyridinone) chelator (KC18) for potential use as gallium-68-labeled prostate-specific membrane antigen (PSMA) radiopharmaceutical
por: Xu Zhou, et al.
Publicado: (2021)